A spliced leader contributes the mature 5 ends of many mRNAs in trans-splicing organisms. Trans-spliced metazoan mRNAs acquire an m 3 2,2,7
INTRODUCTION
Spliced leader (SL) RNA trans-splicing contributes a 5Ј terminal exon to pre-mRNAs to form the mature 5Ј end of the mRNA. SL trans-splicing is present in a diverse spectrum of eukaryotes including sarcomastigophoran protozoa (euglenoids and trypanosomes and their relatives), Cnidaria (Hydra vulgaris), flatworms (free-living and parasitic: polyclads, flukes, and tapeworms), nematodes (e.g., Caenorhabditis elegans and Ascaris), and chordates (tunicate, Ciona intestinalis; Nilsen 2001) . Addition of the 5Ј terminal exon from trans-splicing SL RNAs generates cellular mRNAs with a short, conserved sequence in the mRNA 5Ј untranslated region (UTR) and a distinct hypermethylated cap (in metazoa) derived from the donated spliced leader, an N 2,2,7 -trimethyl-GpppN cap (m 3 2,2,7 GpppN or TMG cap). Nontrans-spliced mRNAs have an N 7 -methyl-GpppN RNA cap (m 7 GpppN) with diverse 5Ј UTR sequences. Therefore, two populations of mRNAs coexist in metazoan cells that exhibit spliced leader addition: trans-spliced and non-transspliced mRNAs.
Both mRNA cap and 5Ј UTR sequence and structure are known to play important roles in translation, and cap structure is also an important determinant in transcript stability. The mRNA cap is recognized and bound directly or indirectly by a number of different cap-binding proteins. Capbinding or -interacting proteins include the translation initiation factor eIF4E (Gingras et al. 1999; Von Der Haar et al. 2004) , nuclear cap-binding complex (consisting of capbinding proteins CBP 20 and 80; Izaurralde et al. 1994 Izaurralde et al. , 1995 , and decapping proteins (Dcp1, Dcp2, and DcpS; for review, see Decker and Parker 2002) . Proteins that interact with the metazoan hypermethylated cap (m 3 and/or spliced leader sequence of a trans-spliced mRNA are likely to play an important role in mRNA metabolism, and may mediate the use and/or cellular discrimination of transspliced versus non-trans-spliced mRNAs.
Decapping proteins are involved in cleaving the unusual 5Ј-ppp-5Ј phosphodiester linkage in the RNA cap (G-5Ј ppp 5Ј -N). The presence of the RNA cap triphosphate bridge increases mRNA stability presumably as it prevents 5Ј to 3Ј exoribonuclease degradation of the mRNA. mRNA decay pathways have been extensively characterized in yeast and more recently in higher eukaryotes. A major mechanism of mRNA decay in yeast proceeds from 5Ј to 3Ј following removal of the cap. Decay is initiated by deadenylation of the mRNA (Tucker and Parker 2000; Parker and Song 2004) . This typically leads to decapping of the intact RNA by a protein complex known as Dcp1/Dcp2 (Beelman et al. 1996; Dunckley and Parker 1999; Parker and Song 2004) . Removal of the cap exposes the 5Ј end of the RNA to exoribonucleolytic decay by Xrn1. A second general pathway, often called the 3Ј to 5Ј pathway, involves deadenylation of the mRNA followed by 3Ј to 5Ј exoribonuclease degradation of the mRNA body by the exosome (Tucker and Parker 2000; Parker and Song 2004) . Processive 3Ј to 5Ј degradation of the mRNA body finally leads to the production of a 5Ј cap dinucleoside triphosphate (m GpppN or oligonucleotide cap is subsequently hydrolyzed by what has been named a "scavenger" decapping activity (DcpS; Nuss et al. 1975; Wang and Kiledjian 2001; Liu et al. 2002) . The 3Ј to 5Ј pathway is typically considered a less active pathway for mRNA turnover in yeast. However, a recent genomewide analysis of mRNA decay using expression profiling and various mutant yeast strains suggests the possibility that the 3Ј to 5Ј decay may be more important than previously realized (He et al. 2003) . Yeast cells blocked in both the 5Ј to 3Ј and 3Ј to 5Ј pathways are not viable, illustrating the importance of mRNA turnover in gene expression (Anderson and Parker 1998) .
The predominant general pathway of mRNA decay in higher eukaryotes is currently unclear. Experiments using mammalian cells, and particularly in vitro studies, suggest that an important mechanism is through the 3Ј to 5Ј decay pathway (Chen et al. 2001; Wang and Kiledjian 2001; Mukherjee et al. 2002) leading to cap dinucleoside triphosphate, m 7 GpppN, which is cleaved by the scavenger activity (DcpS; Wang and Kiledjian 2001) . Both types of decapping activity, DcpS and Dcp1/Dcp2, have been described in mammalian cells (Gao et al. 2001; Wang and Kiledjian 2001; Wang et al. 2002; Lejeune et al. 2003) . A recent RNAi study demonstrated that the C. elegans 5Ј to 3Ј exoribonuclease is required in the latter stages of embryogenesis when epithelial cell movements are required for ventral closure (Newbury and Woollard 2004) . Overall, however, the nature and contribution of different mRNA decay pathways and decapping enzymes to mRNA turnover and their importance in development or viability in multicellular organisms have not been characterized.
SL1 trans-splicing is responsible for the maturation of ∼50 to 90% of mRNAs in the nematodes C. elegans and Ascaris, respectively (Zorio et al. 1994; Maroney et al. 1995) . The function(s) of SL1 trans-splicing in nematode gene expression remains unknown. Among the possible post-transcriptional functions that have been postulated for addition of the TMG-capped-SL sequence to mRNAs are roles in mRNA translation, stability, processing, localization, and/or transport. SL1 trans-splicing is required for early C. elegans development (Ferguson et al. 1996) , and the SL1 sequence with its TMG cap have been shown to functionally collaborate to enhance translational efficiency of a trans-spliced mRNA in an in vitro system (Maroney et al. 1995) . However, our in vitro and in vivo translation studies in Ascaris embryos indicate that the TMG-capped-SL sequence does not confer a measurable translational advantage on recipient mRNAs (L.S. Cohen, M. Mikhli, C. Friedman, M. Jankowska-Anyszka, J. Stepinski, E. Darzynkiewicz, and R.E. Davis, unpubl.; S. Lall, C. Friedman, M. JankowskaAnyszka, J. Stepinski, E. Darzynkiewicz, and R.E. Davis, in prep.) . A second SL sequence (SL2) with a hypermethylated cap and sequence divergent from SL1 (∼50% sequence similarity) is also present in C. elegans (Huang and Hirsh 1989) . SL2 is added to internal splice acceptor sites between mRNAs in polycistronic primary trancripts contributing to the maturation of these operon RNAs into monocistronic mRNAs (Spieth et al. 1993; Blumenthal and Gleason 2003) . Although SL1 trans-splicing is capable of resolving polycistronic transcripts under some conditions, it is unclear whether this is a primary function of SL1 trans-splicing and the overall function of SL1 remains unclear Liu et al. 2001) .
Several decapping enzymes that hydrolyze the m 7 GpppN cap on mRNAs or free cap dinucleoside triphosphates have recently been characterized in yeast and mammalian cells (Beelman et al. 1996; LaGrandeur and Parker 1998; Dunckley and Parker 1999; Wang and Kiledjian 2001; Liu et al. 2002; Lykke-Andersen 2002; Salehi et al. 2002; van Dijk et al. 2002 van Dijk et al. , 2003 Wang et al. 2002; Piccirillo et al. 2003) . mRNA decay, deadenylation, and decapping activities have also recently been described in trypanosomes (Milone et al. 2002 (Milone et al. , 2004 . However, activities in other species have not been well characterized, and neither mRNA decay pathways nor decapping activities have been examined directly in trans-splicing metazoa. In trans-splicing metazoa, the two distinctly capped mRNA populations, and particularly the presence of a distinct cap and the SL sequence on some mRNAs may have a profound influence on mRNA translation and stability. Analysis of the decay pathways and associated proteins may provide insight into the function of trans-splicing, and could lead to potential targets for rational drug design against a number of divergent parasitic worms. In this paper, we describe mRNA transcript decay GpppG.
RESULTS

Decay and decapping activity in Ascaris embryo whole cell extracts
Two distinct mRNA cap-cleaving activities have been described in eukaryotes. One activity, Dcp1/Dcp2, decaps m 7 GpppN-mRNA substrates producing m 7 Gpp + pN-RNA products (Beelman et al. 1996; Lykke-Andersen 2002; van Dijk et al. 2002; Wang et al. 2002; Steiger et al. 2003) . A second activity described as a scavenger activity, DcpS, hydrolyzes N centration (data not shown). Similar results were obtained using an ∼1 kb RNA with a complete open reading frame and poly(A)-tail and an actin mRNA (data not shown).
Several lines of evidence suggest that the m 7 Gp* product observed in the whole cell extract decay reactions results from (1) 3Ј to 5Ј exoribonucleolytic decay of the RNA producing a short m 7 Gp*ppG substrate that is (2) rapidly cleaved by a dinucleoside triphosphate hydrolase ("scavenger" or DcpS-like) activity. The exosome and 3Ј to 5Ј exoribonucleolytic RNA decay in other systems are known to require Mg ++ and are inhibited by EDTA. Notably, m 7 Gp* derived from RNA substrates in the Ascaris embryo extracts is greatly reduced in the presence of EDTA (Fig. 1A, Gp*ppG product generated by the exosome, reducing substrate available for the scavenger decapping activity, and a consequent reduction in m 7 Gp* product. Addition of either an 85 nucleotide poly(A)-tail or G 16 to the 3Ј end of the RNA, sequences known to reduce 3Ј to 5Ј exonucleolytic decay of RNA substrates, did lead to a decrease in m 7 Gp* product (Fig. 1C , cf. lane 5 and lanes 2,4). The most striking example of decreased m 7 Gp* product as a result of decreased 3Ј to 5Ј exoribonucleolytic decay is observed when the spliced leader RNA (SL snRNA) is the substrate. This small 110 nucleotide RNA is predicted to form a three-stem-loop structure, and is known to assemble into a complex SL RNP in Ascaris embryo extracts Denker et al. 1996 Denker et al. , 2002 . We predict this SL RNP would be relatively resistant to 3Ј to 5Ј exoribonucleolytic decay, leading to minimal m 7 Gp*ppG substrate formation. As predicted, low levels of m 7 Gp* were generated in the extracts from the SL snRNA substrate (Fig. 1D , cf. lanes 2 and 4). Addition of the spliced leader sequence alone to the 5Ј end of a truncated mRNA is not predicted to lead to the formation of a complex structure and RNP, and does not similarly reduce m 7 Gp* formation (Fig. 1D , cf. lane 3 and lanes 2,4). We interpret the sum of these observations (EDTA inhibition of the 3Ј to 5Ј decay, m 7 GpppG accumulation following inhibition of scavenger activity, and 3Ј poly(A) or (G) and SL snRNP structure leading to reduction in m 7 Gp* formation) to indicate that the rate-limiting step in the complete decay of the RNA in these reactions is the 3Ј to 5Ј exoribonucleolytic decay of the RNA. In support of this interpretation, incubation of a labeled RNA containing a 3Ј subterminal G 16 or G 30 tract in the extract leads to the predicted 3Ј-5Ј decay intermediate stalled at the G-tracts as shown in other systems (data not shown; Anderson and Parker 1998; Milone et al. 2002) The combined activity of 3Ј to 5Ј exoribonucleolytic decay and scavenger cleavage of the resulting cap dinucleoside triphosphate product were observed on a number of different RNA substrates. In addition, similar decay, RNA decapping, and dinucleoside triphosphate hydrolase activities were also observed in C. elegans whole cell embryo extracts (Supplementary Fig. 2F ; data not shown). Gp*ppG) RNA was prepared by hypermethylation of an m 7 Gp*ppG cap-labeled SL snRNA in Ascaris embryo extracts as previously described . SL snRNA hypermethylation is not complete in these reactions, leading to a mixed substrate containing m 7 Gp*ppG m and m 3 2,2,7 Gp*ppG m capped SL snRNAs as deduced from nuclease P1 and T1 digestion and TLC and PAGE analysis of the products ( Gp*ppG products. Both products are then substrates for a scavenger dinucleoside triphosphate hydrolase(s) that cleaves both cap structures.
Scavenger activity on mono-and trimethylated caps in Ascaris extracts
The scavenger decapping activity on m 7 Gp*ppG m and m 3 2,2,7 Gp*ppG m was further directly examined in the Ascaris embryo extracts using dinucleoside triphosphate substrates generated by P1 nuclease cleavage of cap-labeled RNAs. The nematode scavenger activity was shown to cleave both m 7 Gp*ppG m and m 3 2,2,7 Gp*ppG m substrates (Fig. 2C, lanes 2,4) . The scavenger hydrolase activity in Ascaris embryo extracts is robust, 5.3 × 10 −12 mol/min/mg protein using 0.1 fmole of m 7 Gp*ppG substrate. Extract scavenger activity is at least 50% less active on a m 3 2,2,7 Gp*ppG m substrate compared to that observed with a m 7 Gp*ppG m substrate (Fig. 2C , cf. lanes 2 and 4). Reduced activity of the scavenger enzyme on the trimethylcompared to the monomethyl-cap substrate is supported by inhibition studies that indicate m 7 GpppG is a stronger competitive inhibitor of the nematode scavenger activity than m 3 2,2,7
GpppG (Table 1 ; data not shown). Scavenger hydrolysis of Gp*ppG in the extracts is low, demonstrating the activity has a preference for N 7 -methylation of the cap (Fig. 2C , cf. lanes 2, 4, and 6). In addition, similar decay and decapping activities were also observed in C. elegans embryo extracts (Supplementary Fig. 2F ; data not shown).
Direct RNA decapping and relative levels of scavenger and RNA decapping activities in Ascaris extracts
Direct RNA decapping of m 7 Gp*ppG-RNA and m 3 2,2,7 Gp*ppG m -SL snRNA by a Dcp1/Dcp2 type activity producing m 7 Gp*p and m 3 2,2,7 Gp*p was also observed in Ascaris whole embryo extracts with the addition of Mn ++ and the use of a more sensitive denaturing PAGE assay (Fig.  3 , lanes 2,4). These assays were also carried out with either cold m 7 GpppG or m 7 GDP competitor to attempt to enhance and facilitate Dcp1/Dcp2 product formation as previously described (Gao et al. 2001) . These cap analogs can inhibit scavenger decapping activity and sequester capbinding proteins, which may facilitate better access of Dcp1/ Dcp2 to the RNA cap. In general, use of cap analogs to sequester cap-binding proteins did not significantly enhance (Յtwofold) our ability to detect potential Dcp1/Dcp2 GDP can comigrate with inorganic phosphate (iP) in this system, the product in lane 5 was shown to be iP based on the absence of its accumulation when phosphatase inhibitors were included in the reaction and the lack of conversion of this product to a triphosphate when incubated with nucleoside diphosphokinase (data not shown; Wang and Kiledjian 2001) . Note that the Gp*p and Gp*pp spots are derived from the cap-labeling reaction and are not present in gel-purified RNA substrates that were used in other experiments with similar results. The reaction in lane 5 was carried with an approximately fivefold higher extract protein and longer incubation times than the reactions illustrated in Figure GpppG mRNA decapping www.rnajournal.org activity and guanosine diphosphate product formation in the nematode extracts (Fig. 3 , cf. lanes 2-5). Mn ++ enhances the nematode extract Dcp1/Dcp2 activity (L.S. Cohen, M. Mikhli, C. Friedman, M. Jankowska-Anyszka, J. Stepinski, E. Darzynkiewicz, and R.E. Davis, unpubl.) as described for the yeast and human enzymes (Wang et al. 2002; Steiger et al. 2003) . However, even in the presence of Mn ++ (Fig. 3) , we observed only relatively low levels of Dcp1/Dcp2 activity using a variety of extract preparations and different assay conditions. Although Dcp1/2 type activity and its products (m 7 Gp*p and m 3 2,2,7 Gp*p) are observed in the Ascaris extracts, the predominant decapping products observed are monophosphates consistent with a dinucleoside triphosphate or oligonucleotide "scavenger" decapping activity (DcpS). We estimate that the combined activity of 3Ј to 5Ј exoribonucleolytic decay of the RNA substrate and scavenger dinucleoside triphosphate hydrolysis of the resulting cap dinucleotides by the scavenger is at least ∼15-fold greater (and ∼60-fold in the absence of Mn ++ ) than the activity of Dcp1/Dcp2 RNA decapping activity in the extract (Fig. 3 , lane 2; data not shown).
Overall, we have observed two types of decapping activities (scavenger-and Dcp1/Dcp2-like) in Ascaris extracts, each of which can cleave mono-and trimethylated caps. We have further shown that a recombinant C. elegans Dcp2 can directly decap m 3 2,2,7 Gp*ppG m -SL snRNA producing m 3 2,2,7 Gp*p ( Supplementary Fig. 1E , lanes 8,16).
Cap dinucleoside triphosphate hydrolase and RNA decapping activity in cellular fractions
To assess the distribution of the decapping enzyme activity in several cellular fractions, whole-cell embryo extracts were subjected to some initial fractionation as described in the Materials and Methods, and the fractions assayed for both DcpS and Dcp1/Dcp2 type activities. DcpS activity, assessed by dinucleoside cap cleavage leading to m 7 Gp* or m 3 2,2,7 Gp*, was observed in the 27,000 × g (S27) and 130,000 × g (S130) supernatant fractions, but reduced in the 130,000 × g pellet fractions and nuclear extracts (Fig.  4A,C) . 3Ј to 5Ј exoribonuclease activity (producing cap dinucleoside triphosphate or combined with scavenger activity, m 7 Gp* or m 3 2,2,7 Gp*) was observed in all of the fractions examined, although lower levels were observed in nuclear extracts and the 130,000 × g pellet (Fig. 4B,C) . Dcp1/Dcp2 RNA decapping activity was observed in all fractions including the S27 supernatant, S130 pellet, S130 pellet salt wash, and nuclear extracts (see Fig. 4B ,C; data not shown) with the highest levels observed in the S130 pellet and S130 pellet salt wash. Thus, the two decapping activities exhibit differences in their cellular fractionation.
A C. elegans protein with scavenger DcpS activity
Because a DcpS ortholog likely carries out the scavenger activity observed in nematode extracts, we searched for and identified a putative C. elegans ortholog of the human DcpS in the C. elegansЈ database. The C. elegans DcpS open reading frame was amplified by RT-PCR, cloned into a bacterial expression vector, and the bacterially expressed 6×-Histagged protein purified by Ni 2+ -NTA agarose and then ion exchange chromatography. The purified protein (>90% pure; Fig. 5A ) is ribonuclease-free and readily cleaved m 7 Gp*ppG dinucleoside triphosphate to m 7 Gp* demonstrating that the identified C. elegans protein exhibited scavenger dinucleoside triphosphate hydrolase activity (Fig. 5B) . The specific activity of the recombinant C. elegans DcpS for m 7 Gp*ppG is ∼2 × 10 −11 moles/min/mg protein. A similarly purified recombinant human DcpS protein was also prepared and assayed for a comparison of activities and substrate specificity (see below; Fig. 5A ).
C. elegans DcpS Hydrolyzes up to m
7 Gp*ppG + 2 nucleotide substrates, but not longer substrates To examine the substrate length requirement of the nematode DcpS, cap-labeled m 7 Gp*ppGN n oligonucleotide substrates of different lengths were prepared using nuclease P1 or RNase A digestion of different cap-labeled RNAs (see Materials and Methods). As illustrated in Figure 5C (lanes 7,8), m 7 Gp*ppG and m 7 Gp*ppG + 2 nucleotide substrates were readily cleaved to m 7 Gp* by C. elegans DcpS, but dinucleoside triphosphate cap substrates with 3-6 addi- tional 3Ј nucleotides (lanes 9-12) were poor substrates for the dinucleoside triphosphate hydrolase activity. The recombinant human enzyme, by comparison, readily cleaves cap dinucleosides triphosphates with up to four additional nucleotides and retains some activity with m 7 Gp*ppG + 6 oligonucleotide (Fig. 5C, lanes 13-18) . These data on the human enzyme are in agreement with those described by Wang et al. (2002) , who demonstrated that the human enzyme retains some activity on substrates as long as 10 nucleotides. Thus, nematode DcpS requires a shorter substrate than the human enzyme and exhibits minimal hydrolase activity on m 7 Gp*ppG + 3 nucleotides or greater.
2-O-Ribose is methylated in nematode caps
Capped RNAs from higher eukaryotes typically contain a 2Ј-O-methyl in the ribose of the first and second template encoded bases of the RNA (known as cap 2). Lower eukaryote mRNAs such as yeast do not have 2Ј-O-methyl added to the mRNA cap (Cap 0; Mager et al. 1976; Sripati et al. 1976) . The Ascaris SL snRNA has an m 3 2,2,7
GpppG m cap (cap 1) as shown by analysis of an in vivo 32 P-labeled SL snRNA (Maroney et al. 1990a,b) . Transfer of the m 3 2,2,7 GpppG m cap 1 with the 22 nucleotide spliced leader to mRNAs by trans-splicing (Liou and Blumenthal 1990; Van Doren and Hirsh 1990) Gp*ppG m caps from cap-labeled RNAs treated with nuclease P1 (see Supplementary Fig. 2A-D) . As we observed hydrolysis of both methylated and hypermethylated dinucleoside cap substrates in the Ascaris embryo extracts, we hypothesized that the C. elegans DcpS would cleave both m 7 Gp*ppG and m 3 2,2,7 Gp*ppG caps. As hypothesized, both substrates were in fact converted to their respective Gp* products (Fig. 6A, panels 1-3) .
We then compared the substrate specificity of C. elegans and human DcpS for cap 0 and cap 1 m 7 GpppG and m 3 2,2,7
GpppG. As illustrated, both the nematode and human enzymes are active on either m 7 GpppG cap 0 or cap 1 (Fig. 6A,B, panels 1,2) . The C. elegans DcpS is also active on both cap 0 or cap 1 m 3 2,2,7 GpppG (Fig. 6B, panel 3 ; data not shown). However, under similar assay conditions, the human DcpS enzyme did not hydrolyze either m 3 2,2,7 GpppG cap 0 or cap 1 (Fig. 6 , cf. A and B, panel 3; data not shown). Thus, the recombinant nematode DcpS has significant m 3 2,2,7
GpppG hydrolase activity compared to the human enzyme. Furthermore, the 2Ј-O-methyl ribose does not significantly affect the activity of either the nematode or human DcpS.
C. elegans DcpS has minimal activity on a guanine dinucleoside triphosphate substrate that is not methylated (Gp*ppG) compared to methylated caps (Fig. 6A, panel 4) . However, at ∼100 ng recombinant protein a small, but detectable amount of Gp*ppG hydrolysis is observed. Very high levels of recombinant C. elegans DcpS protein (∼500 ng) in an extended incubation lead to more efficient hydrolysis (see Supplementary Fig. 2D, lanes 5,8) . Notably, the specificity for which phosphodiester bond is hydrolyzed appears reduced with the Gp*ppG substrate as both Gp* and Gp*p products are observed. Only monophosphate products are typically observed with methylated caps even with GpppG, the reactions phenol:chloroform extracted, resolved by 25% denaturing PAGE, and products detected by autoradiography. Note the relative ratios of monophosphate (3Ј to 5Ј decay and scavenger activity) and diphosphate (Dcp1/Dcp2-like activity) nucleotide decay products in lanes 2 and 4. The diphosphate products do not increase dramatically when scavenger activity is inhibited with m GpppG mRNA decapping www.rnajournal.org excess DcpS protein. In comparison, up to 100 ng of human DcpS under the same assay conditions had almost no activity on a Gp*ppG substrate (Fig. 6B, cf. panel 4) .
Competition experiments were also carried out using dinucleoside triphosphates and nucleotide competitors to gain further insight into the substrate specificity of the recombinant nematode DcpS enzyme. The concentration of competitor required to produce 50% inhibition of the recombinant enzyme is shown in Table 1 GpppA) were significantly less active as inhibitors (64 or 74 µM required for 50% inhibition). The 3Ј nucleotide in a methylated guanine dinucleoside triphosphate does not lead to significant differences in level of inhibition. This is consistent with the likely variation in the +1 nucleotide of different non-trans-spliced mRNA transcripts. Neither ApppG nor nonmethylated guanine dinucleoside triphosphate (GpppG) or guanine nucleotides inhibited the enzyme. Interestingly, although trimethylated dinucleoside triphosphate substrates (m 3 2,2,7 GpppG) can inhibit the enzyme, the trimethylated nucleotide diphosphate (m 3 2,2,7 GDP) demonstrated minimal inhibition. In addition, nucleotide concentrations required for 50% inhibition of the nematode recombinant enzyme were in general approximately five-to eightfold higher than those observed for the human DcpS enzyme.
C. elegans DcpS binds to both m 7 GTP-and m 3 2,2,7 GTP-sepharose
The previous experiments indicated that C. elegans recombinant DcpS hydrolyzes m 3 2,2,7 GpppG, whereas the human enzyme has minimal activity on this hypermethylated cap. To independently examine cap binding to mono-and trimethylguanosine nucleotides, capbinding affinity experiments (Table 2) were carried out using the recombinant nematode and human DcpS enzymes and m 7 GTP-and m 3 2,2,7 GTP-Sepharose as previously described (Jankowska-Anyszka et al. 1998; Keiper et al. 2000; Miyoshi et al. 2002) . The recombinant nematode DcpS protein bound with equivalent efficiency to the m 7 GTP-and m 3 2,2,7 GTP-Sepharose. In contrast, the human DcpS protein bound very poorly to m 3 2,2,7 GTP-Sepharose and bound more tightly than C. elegans DcpS to the m 7 GTP-Sepharose. As a positive control we used another nematode cap-binding protein, Ascaris eIF4E, which binds equally to both m 7 GTP-and m 3 2,2,7 GTP-Sepharose (S. Lall, C. Friedman, M. Jankowska-Anyszka, J. Stepinski, E. Darzynkiewicz, and R.E. Davis, in prep.). As negative controls that do not bind cap alone, we used C. elegans Dcp2 (L.S.
Cohen, M. Mikhli, C. Friedman, M. Jankowska-Anyszka, J.
Stepinski, E. Darzynkiewicz, and R.E. Davis, unpubl.) and nuclear cap-binding protein 80 (CBP80; R.E. Davis, unpubl.). These data are consistent with and provide additional experimental support to the cleavage studies (Fig.  6A,B, panel 3 ) that indicate the nematode DcpS has a higher affinity for trimethylated guanine nucleotides than does the human DcpS. GMP by recombinant human DcpS were described (van Dijk et al. 2003) . These studies suggested care should be taken in interpreting the contribution of different cellular decapping activities simply based on the accumulation of m Stepinski, E. Darzynkiewicz, and R.E. Davis, unpubl.). Using similar assay conditions as described by van Dijk et (Fig. 7A, panels 3,4) . The activity responsible for this conversion could be one of several different enzymes. Importantly, (1) the percentage of m 7 GMP derived from m 7 GDP in the extracts would contribute only a very small percentage of total m 7 GMP to our in vitro decapping reactions, and (2) the levels of m 7 GDP produced do not increase more than twofold in extract assays when DcpS is inhibited with m 7 GpppG. This suggests it is unlikely the major m 7 Gp* products observed in our whole embryo extract assays represent significant levels of DcpS conversion of m 7 Gp*p derived from Dcp1/Dcp2 decapping of RNA, and that our estimates of the relative amounts of DcpS compared to Dcp1/Dcp2 activity are not subject to this limitation. Our interpretation of the data is that the predominant decay/decapping pathway in nematode embryos utilizes 3Ј to 5Ј exonuclease decay of the RNA followed by scavenger cleavage of the produced m 7 GpppN and m 3 2,2,7 GpppG dinucleoside triphosphates.
DISCUSSION
Summary
Analysis of decapping activities in nematode embryo extracts indicates the predominant activity is a scavenger decapping activity (DcpS-like) that hydrolyzes m 7 GpppG and m 3 2,2,7
GpppG products of 3Ј to 5Ј exoribonucleolytic RNA decay. Dcp1/Dcp2-like RNA decapping activity is detectable in nematode embryo extracts but present at significantly lower levels. Scavenger activity is very robust, and the combined activities of 3Ј to 5Ј exoribonucleolytic decay of RNA followed by N 7 -guanosine nucleoside triphosphate hydrolase activities greatly exceeds (∼15-fold) that observed for direct decapping of RNA by Dcp1/Dcp2-like activity. These data suggest that 3Ј to 5Ј decay appears to be the predominant general pathway of decay in nematode embryo extracts and may be the default pathway for mRNA degradation in vitro, at least for the RNA substrates examined.
Our characterization of C. elegans recombinant DcpS activity indicates the enzyme has limited activity on guanosine dinucleoside triphosphates (GpppG) unless the first base is methylated at the N 7 position. Nematode scavenger enzyme readily hydrolyzes m Gp*ppG m -SL snRNA was incubated in Ascaris embryo extract and analyzed as described in Figure 3 . Exosome/DcpS activity is defined by the formation of m Gp*p. Note that both the DcpS and Dcp1/Dcp2 products are produced from the two capped RNA substrates. Hypermethylated SL snRNA is 50% monomethylated and 50% trimethylated as illustrated in Figure 2A Gp*p products of Dcp1/Dcp2, although limited, are highly reproducible. It should be noted that Dcp2 has reduced activity on RNA substrates with the spliced leader sequence (L.S. Cohen, M. Mikhli, C. Friedman, M. Jankowska-Anyszka, J. Stepinski, E. Darzynkiewicz, and R.E. Davis, unpubl.), the substrate used to generate the hypermethylated cap. (C) 3Ј to 5Ј decay/DcpS, scavenger, and Dcp1/Dcp2 activity in nuclear extracts. m 7 Gp*ppG-cap-labeled RNA (lanes 1-6) or m 7 Gp*ppG dinucleoside triphosphate (lanes 7-10) was incubated in Ascaris embryo extract fractions and analyzed as described in Figure 3 . Nuclear extracts were prepared as described in Materials and Methods. GpppG, as illustrated by both direct hydrolysis of cap-labeled substrates (at least 2:1) and inhibition assays. Notably, in comparison, human DcpS has minimal activity on the trimethylated cap (m 3 2,2,7 GpppG) and is active on longer oligonucleotide substrates. The data suggest there are differences between the human and nematode DcpS enzymes in the substrate binding pocket and/or its flexibility.
Structural basis for DcpS substrate requirements
Recently, the structure of human DcpS bound to m 7 GpppG or m 7 GpppA and insight into the mechanism of DcpS were reported (Gu et al. 2004 ). The DcpS structure indicates the protein is an asymmetric dimer that contains both an open nonproductive and a closed productive DcpS-cap complex. Many residues interact with the cap and/or each other to create a pocket that is favorable for m 7 GpppG binding, as well as the structural changes associated with the closing of the pocket and subsequent cleavage of the cap. Differences in substrate and substrate length specificity observed among Schizosaccharmyces pombe (substrate can be a full-length capped RNA), nematodes (both m GpppG cap and Cap + 2 nucleotides), and humans (Cap + 10 nucleotides) suggests that the binding pocket of DcpS enzymes exhibit unusual flexibility or distinct structural features associated with the open and closed conformations for cap binding and cleavage. It remains to be determined what overall structural determinants contribute to these differences.
We have identified a variety of additional DcpS orthologs in databases ranging from early eukaryotes (Tetrahymena, Entamoeba, Chlamydomonas, and a diatom) and metazoa including DcpS sequences from organisms with transsplicing (tunicate: Ciona; flatworm: Schistosoma; C. elegans, and two additional parasitic nematodes: Brugia malayi and Heterodera glycines; data not shown). Comparison of these sequences (particularly DcpS orthologs from trans-splicing organisms) with the mechanistic and structural information derived from analysis of human DcpS will enable us to carry out Bacterially expressed, histidine tagged C. elegans and human DcpS were purified using nickel affinity and then Q-Sepharose Fast Flow column chromatography. Purified protein preparations were >90% pure based on Coomassie Blue staining of SDS-PAGE gels. (B) Recombinant C. elegans DcpS hydrolyzes m nematode DcpS structure/function studies that should provide insight into the difference in cap-binding specificity observed in nematodes, and if these differences may be exploitable for rational drug design in the development of new anti-nematode drugs.
Nematode scavenger activity and decapping of m 3 2,2,7
GpppG-capped RNAs
During the course of our studies the characterization a C. elegans operon containing a histidine triad protein, dcs-1 was reported (Kwasnicka et al. 2003) . This is the same protein we have characterized as C. elegans DcpS. Our data are in general agreement with their kinetic analysis and inhibition data indicating that the protein is relatively specific for GDP were in the 2.2-3.5-µM range, and the K i value for trimethylated cap was 28 µM, approximately eightfold higher than the monomethylated nucleotides. From their K i data, Kwasnicka et al. (2003) concluded that the scavenger enzyme was not likely to function on m 3 2,2,7 GpppG-capped snRNAs. Our data indicate that the protein can function on an m 3 2,2,7
GpppG-capped snRNA, the SL snRNA, as well as a U1 snRNA (data not shown). In addition, of seminal importance in our view is whether the scavenger activity in nematodes is sufficient to act on m 3 2,2,7
GpppG derived from trans-spliced mRNAs representing ∼70% of the nematode mRNA population. Although the substrate affinity of nematode DcpS is clearly significantly lower for m 3 2,2,7
GpppG than m 7 GpppG, the levels of scavenger activity in nematode extracts are very high. DcpS activity associated with the exosome complex (or subset of exosome complex proteins) actively engaged in 3Ј to 5Ј RNA decay could also have altered kinetic properties, and might have access to higher local concentrations of substrate. Human DcpS activity was previously shown to be present both in free form and a complex, likely the exosome (Wang and Kiledjian 2001) . We have made similar observations in the Ascaris extracts (data not shown). We have rarely observed significant accumulation of m 3 2,2,7 GpppG or m 7
GpppG caps in our embryo extract decay reactions (or in vivo following biolistic introduction of labeled RNAs; L.S. Cohen, M. Mikhli, C. Friedman, M. JankowskaAnyszka, J. Stepinski, E. Darzynkiewicz, and R.E. Davis, unpubl.) where endogenous mRNAs in the extracts are simultaneously undergoing decay. Taken together, the high levels of nematode embryo DcpS-like activity, the in vitro decay data, and the likely association of DcpS with the exosome complex (data not shown) suggests to us that the activity in vivo is likely to be sufficient to hydrolyze both m 3 2,2,7
GpppG and m 7 GpppG caps derived from 3Ј to 5Ј decay. Alternatively, it remains possible that additional scavenger activities are present in nematodes that can hydrolyze trimethylguanosine GTP-Sepharose − FIGURE 6. Comparison of cap substrate hydrolysis for recombinant C. elegans and human DcpS. Cap cleavage reactions were carried out at 30°C with recombinant C. elegans DcpS (A) or 37°C with recombinant human DcpS (B) for 30 min using TLC purified and characterized substrates. Reactions were carried out and analyzed as described in Figure 2C using 25% denaturing PAGE and detected by autoradiography. Control reactions using a similarly purified recombinant protein (␤-galactosidase) demonstrated no degradation of RNA or cleavage of cap dinucleotides. caps. Recently, a U8 snoRNA binding protein was identified as a nuclear decapping enzyme active on RNA substrates producing GDP (and its methylated derivatives) and p-RNA products (Ghosh et al. 2004) . Although this protein can cleave m 3 2,2,7 GpppG-capped RNA, and is conserved in vertebrates, it does not appear to be present in the genomes of lower eukaryotes including C. elegans.
Cellular distribution of decapping activities
Our initial extract studies suggest that the DcpS activity is primarily cytoplasmic in 32-64 cell Ascaris embryos. Studies by the Kiledjian laboratory (Liu et al. 2002) also found that the human DcpS protein was primarily found in the cytoplasmic fraction, with little protein observed in the nuclear fraction based on immunoprecipitation experiments. However, analysis of the S. pombe, COS cell, and human DcpS proteins using fluorescence and immunocytochemistry indicate that they localize primarily to the nucleus (Salehi et al. 2002; Kwasnicka et al. 2003; Cougot et al. 2004; M. Kiledjian, pers. comm.) . The predominantly nuclear localization of the COS cell DcpS led Kwasnicka et al. (2003) to propose that the enzyme might function to decap aberrant transcripts in the nucleus that might result under stress conditions. Studies are currently underway in our laboratory to examine the localization of DcpS protein using immunocytochemistry in developing nematode embryos and to examine the interaction of nematode DcpS with other cap-binding proteins and exosome components.
Conclusion
The nematode-decapping enzymes, DcpS and Dcp1/Dcp2, have the ability to hydrolyze the typical eukaryotic m 7 GpppG cap as well as the m 3 2,2,7 GpppG cap added to mRNAs through trans-splicing. An in vitro decay system is described that indicates RNA decay by a 3Ј to 5Ј pathway followed by DcpS hydrolysis of the resulting cap appears to be the predominant nematode decay pathway in embryo extracts. These studies provide the foundation for further studies to characterize the contribution and interplay of translation and decay in the expression of trans-spliced and non-trans-spliced nematode mRNAs.
MATERIALS AND METHODS
Preparation of whole-cell embryo and nuclear extracts
Whole-cell extracts were prepared from 32-64 cell Ascaris suum embryos using methods similar to those described by Nilsen and collaborators (Hannon et al. 1990a,b; Maroney et al. 1995 ) with a metal dounce, 10 mM KCl, and protease inhibitors. These Ascaris embryo extracts are competent for cap-dependent translation and exhibit mRNA cap and poly(A)-tail synergism (S. Lall, C. Friedman, M. Jankowska-Anyszka, J. Stepinski, E. Darzynkiewicz, and R.E. Davis, in prep.) . In some experiments, extracts were prepared with a modified buffer system (10 mM Tris-HCl, pH 7.5, 1 mM KoAc, 1.5 mM MgoAc, 1 mM DTT, and protease inhibitors) and crudely fractionated as described (Brewer and Ross 1990; Ross 1999; Wang and Kiledjian 2000) . Ascaris embryo nuclear extracts were prepared as described (Seidl and Moritz 1998) , the nuclear pellets extracted with either 400 mM KCl or 350 mM NaCl, and the resulting nuclear extracts dialyzed. C. elegans whole-cell embryo extracts were generously provided by Margaret MacMorris and Tom Blumenthal.
Transcription template and RNA preparation
PCR templates (see Supplementary Fig. 1 ) for in vitro transcription reactions were prepared from Promega plasmid pRLnull or pAscSL_snRNA using primers provided in the Supplementary Figure 1 . These PCR reactions generate templates with a T7 promoter, different 5Ј UTRs with or without the spliced leader sequence, and 3Ј ends either with or without a poly(A) tail or a homopolymeric 3Ј G 16 tract. Transcription reactions produced from either a Riboprobe or MegaScript kit as described by the manufacturer (Promega and Ambion) were DNase I-treated, extracted with TRIzol Reagent (Invitrogen), and the RNAs precipitated twice, once with isopropanol and then with ammonium acetate/ethanol. Precipitated RNAs were further washed with 70% ethanol, dissolved in Gp*ppG and the reaction products analyzed by TLC and detected by autroradiography. Recombinant DcpS assays were carried out in a buffer as described (van Dijk et al. 2003 ) for 1 h with the human enzyme at 37°C and the nematode enzyme and extracts at 30°C. Reactions carried out with the decapping buffer used in the current study produced identical results. (B) Illustrates that a similarly purified substrate from the same experiment is a substrate for DcpS. Mixing experiment indicate that the TLC purified m 7 Gp*p is not inhibitory to DcpS hydrolysis of m 7 Gp*ppG in B (data not shown).
water, quantitated spectrophotometrically, and examined by agarose-formaldehyde, denaturing gel electrophoresis.
Cap-labeled substrate preparation
Cap-labeled RNAs were prepared from uncapped RNA substrates using 32 P-␣-GTP (Perkin-Elmer), and recombinant vaccinia RNA guanylyltransferase and (guanine-N 7 )-methyltransferase (generously provided by Stewart Shuman) or human capping enzyme (generously provided by Aaron Shatkin). In some experiments, the cap was further methylated at the 2Ј-O-ribose by inclusion of mRNA cap-specific 2Ј-O-methyltransferase (generously provided by Paul Gershon). For many experiments, cap-labeled RNAs were gel purified by denaturing PAGE prior to use.
Cap-labeled oligonucleotides of defined length (see Fig. 5C ) were derived by treating cap-labeled RNA transcripts (derived from pRLnull, pBlueScript II SK, pGL3 Basic, or the Megascript positive control template) with RNase A and characterized prior to use by thin layer chromatography (TLC) and PAGE.
Cap dinucleoside triphosphates (Gp*ppG, m 7 Gp*ppG or m 3 2,2,7 Gp*ppG, where the * follows the 32 P-labeled phosphate) were typically generated from cap-labeled RNAs by Nuclease P1 (Calbiochem and Sigma) digestion of the RNA (see Supplementary Fig. 2A,B) . In some cases, caps were produced from caplabeled RNAs by T1 digestion (Ambion), which produces caps or capped oligonucleotides with a 3Ј phosphate. To generate pure cap-labeled substrates, labeled RNAs and caps were either gel purified or purified by TLC and elution of individual substrates in 1× decapping buffer.
Ascaris m 3 2,2,7
Gp*ppG m -SL snRNA was produced by hypermethylation of an m 7 Gp*ppG m -SL snRNA in Ascaris whole-cell embryo extracts and purified as previously described ).
Whole cell extract decay analysis
Ascaris embryo extract mRNA decay and decapping assays were carried out using the decapping buffer of Zhang et al. (1999) (50 mM Tris, pH 7.9, 30 mM (NH 4 ) 2 SO 4 , 1 mM MgCl 2 , 1 mM DTT) with the addition of 2.5 mM MnCl 2 , which increases Dcp2 activity. RNA substrates in the reactions ranged from ∼0.04-13 ng (0.5-163 fmole) per reaction, corresponding to 5000-160,000 dpm. Cap dinucleoside triphosphate substrates (e.g., m 7 Gp*ppG, m 7 Gp*ppG m , or their nonmethylated or hypermethylated derivatives) ranged from ∼500-64,000 dpm/reaction (0.05-0.64 fmole). Reactions typically contained 7.5 µg of protein (protein range in reactions was ∼2-30 µg), the reactions were incubated at 30°C for 30-60 min, and then extracted with 1:1 phenol:chloroform/isoamyl alcohol. For specific activity determinations, reactions were carried out within the linear range of protein and time using a set substrate concentration described in the text. Reactions were spotted onto TLC plates or loaded on denaturing PAGE gels, resolved as described below, and detected by autoradiography.
Cloning, expression, and purification of C. elegans DcpS
Total C. elegans RNA was isolated from mixed stage C. elegans cultures using Trizol. First-strand cDNA was generated using SuperScript II reverse transcriptase and oligo dT primers (Invitrogen). The C. elegans DcpS open reading frame was amplified from the cDNA using specific primers (see Supplementary Fig. 1 ) and Expand High Fidelity Polymerase (Roche). The DcpS coding region PCR product was digested with NdeI and BamHI (Promega) and cloned into pET16b (Novagen) using DH5␣ as a host. Recombinants were identified and confirmed by DNA sequencing. Clones were then transformed into Rosetta DE3 (Novagen) for protein expression. Protein expression was induced with 0.4 mM isopropyl ␤-D-thiogalactoside overnight at room temperature. Frozen bacterial pellets were resuspended in ice-cold lysis buffer (20 mM HEPES, pH 7.5, 300 mM NaCl, 300 mM urea, 10% glycerol, 1% Triton X-100, 10 mM imidazole), lysozyme was added to a final concentration of 1 mg/mL, the suspension incubated on ice for 30 min, and then sonicated. The 6×-His-tagged DcpS was bound to Ni 2+ -nitrilotriacetic acid (NTA)-agarose (Qiagen Inc.) for 60 min at 4°C, unbound proteins removed with a washing buffer (20 mM HEPES, pH 7.5, 300 mM NaCl), and the bound proteins eluted with wash buffer containing increasing concentrations of imidazole (20-300 mM imidazole). Fractions containing DcpS were dialyzed against 20 mM Tris pH 7.5, 150 mM NaCl, loaded onto a HiTrap Q FF anion exchange column (Pharmacia) equilibrated in the same buffer, and bound protein eluted with a gradient from 0.15 to 1 M NaCl. Those fractions containing DcpS activity were dialyzed against 0.2 mM EDTA, 20 mM Tris, pH 7.5, 50 mM KCl, 20% glycerol, 1 mM DTT, 0.5 mM PMSF and stored at -80°C. Human DcpS in pET28, generously provided by Kiledjian et al. (Liu et al. 2002) , was expressed and purified in a manner identical to the nematode protein.
Recombinant DcpS assay
Recombinant DcpS cap cleavage assays were carried out as described for the embryo extracts at 30°C for 30 min with ∼1-150 ng of two step purified (His-Tag and anion exchange) recombinant protein. Inhibition assays contained unlabeled dinucleoside triphosphates and guanosine nucleoside phosphates that were premixed in reaction buffer before the addition of the protein. DcpS reactions were stopped on ice, extracted with phenol/chloroform, the reaction products resolved on TLC plates or PAGE gels, and detected by autoradiography. Substrate to product conversion was determined by phosphoimager analysis using Molecular Dynamics STORM 860 and ImageQuant software. For the inhibition experiments, 50% inhibition was determined by graphical analysis of percent conversion of substrate to product and determination of the amount of inhibitor needed for 50% inhibition.
Substrate characterization and dinucleoside triphosphate (cap) cleavage and RNA decapping product analysis
Capped RNA and cap substrates and their reaction products were characterized and identified using a variety of methods including comigration with known standards using TLC or denaturing PAGE analysis and several enzyme shift strategies (treatment with alkaline phosphatase [Roche] Fig. 2 ; data not shown). TLC was carried out using PEI-cellulose as the stationary phase and ammonium sulfate (0.45 M) or lithium chloride (0.75 M) as the mobile phase. PAGE GpppG mRNA decapping www.rnajournal.org analysis was done using 20% or 25% denaturing gels as described (Bergman et al. 2002) . Reaction substrates and products were then quantified by phosphoimager analysis of the TLC or PAGE separations using Molecular Dynamics STORM 860 and ImageQuant software. GTP-Sepharose beads (Jankowska et al. 1993) in binding buffer (20 mM Tris, pH 7.5, 25 mM KCl, 0.2 mM EDTA, 1 mM DTT, 0.5 mM PMSF, 20% glycerol), the samples incubated for 45 min at 4°C with gentle shaking, the sepharose beads washed with binding buffer, and the bound proteins eluted with binding buffer containing 500 mM KCl. Proteins that remained bound to the sepharose beads were removed from the beads by denaturation using heat and Laemmli SDS PAGE loading buffer. Aliquots of the proteins (starting material, flow-through, wash, and eluate) were analyzed by SDS PAGE, stained with SYPRO Ruby (Molecular Probes), and analyzed with a Molecular Dynamics Storm 860 and ImageQuant software. GpppG mRNA decapping www.rnajournal.org
